Axa’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-22,672
| Closed | -$96K | – | 1348 |
|
|
2021
Q2 | $96K | Sell |
22,672
-39,100
| -63% | -$166K | ﹤0.01% | 1243 |
|
|
2021
Q1 | $308K | Hold |
61,772
| – | – | ﹤0.01% | 1136 |
|
|
2020
Q4 | $781K | Hold |
61,772
| – | – | ﹤0.01% | 1012 |
|
|
2020
Q3 | $607K | Buy |
61,772
+15,317
| +33% | +$151K | ﹤0.01% | 1005 |
|
|
2020
Q2 | $462K | Sell |
46,455
-27,628
| -37% | -$275K | ﹤0.01% | 1073 |
|
|
2020
Q1 | $655K | Hold |
74,083
| – | – | ﹤0.01% | 928 |
|
|
2019
Q4 | $683K | Hold |
74,083
| – | – | ﹤0.01% | 945 |
|
|
2019
Q3 | $436K | Sell |
74,083
-31,400
| -30% | -$185K | ﹤0.01% | 1120 |
|
|
2019
Q2 | $1.27M | Buy |
105,483
+77,583
| +278% | +$931K | ﹤0.01% | 932 |
|
|
2019
Q1 | $337K | Buy |
+27,900
| New | +$337K | ﹤0.01% | 1169 |
|
|
2018
Q4 | – | Sell |
-17,300
| Closed | -$257K | – | 1393 |
|
|
2018
Q3 | $257K | Hold |
17,300
| – | – | ﹤0.01% | 1257 |
|
|
2018
Q2 | $291K | Sell |
17,300
-8,900
| -34% | -$150K | ﹤0.01% | 1237 |
|
|
2018
Q1 | $600K | Buy |
+26,200
| New | +$600K | ﹤0.01% | 1124 |
|